| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $40.66 ▼ -0.69% | Yesterday | $41.06 ▲ +0.29% | Tomorrow's Apellis Pharmaceuticals Inc. Common Stock (APLS) setup is anchored to $40.94 and targets $40.66 (-0.69%). The near-term read is downside; watch $42.17 / $39.71 because daily realized volatility is about 3.57%. |
Tomorrow's Apellis Pharmaceuticals Inc. Common Stock (APLS) setup is anchored to $40.94 and targets $40.66 (-0.69%). The near-term read is downside; watch $42.17 / $39.71 because daily realized volatility is about 3.57%. | ||||
| Week | $40.06 ▼ -2.16% | Last Week | $41.31 ▲ +0.91% | The 7-day Apellis Pharmaceuticals Inc. Common Stock model moves from $41.31 to $40.06 (-2.16%). It gives downside momentum context for this stock, so breaks around $42.17 / $39.71 matter more than a single tick. |
The 7-day Apellis Pharmaceuticals Inc. Common Stock model moves from $41.31 to $40.06 (-2.16%). It gives downside momentum context for this stock, so breaks around $42.17 / $39.71 matter more than a single tick. | ||||
| Month | $39.06 ▼ -4.59% | Last Month | $41.73 ▲ +1.93% | The 1-month Apellis Pharmaceuticals Inc. Common Stock target is $39.06 (-4.59%), compared with the live reference near $40.94. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Apellis Pharmaceuticals Inc. Common Stock target is $39.06 (-4.59%), compared with the live reference near $40.94. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $37.57 ▼ -8.24% | Last Year | $42.36 ▲ +3.46% | The 1-year Apellis Pharmaceuticals Inc. Common Stock scenario points to $37.57 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Apellis Pharmaceuticals Inc. Common Stock scenario points to $37.57 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $34.06 ▼ -16.80% | 5 Years Ago | $43.83 ▲ +7.06% | The 5-year Apellis Pharmaceuticals Inc. Common Stock view is $34.06 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Apellis Pharmaceuticals Inc. Common Stock view is $34.06 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $40.94 | Mid |
| Daily Change | 0.00% | Mid |
| Volatility Cap | 20.0% | Mid |
| Confidence | 57% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $40.94 | Daily Change | 0.00% |
| Market Cap | $5.23B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.